Article ID Journal Published Year Pages File Type
8315535 Clinica Chimica Acta 2012 6 Pages PDF
Abstract
► Significantly alterations of cellular immunity in NPC as compared with healthy group. ► Radiochemotherapy result in immunologic changes excepting CD3+ or CD25+ lymphocyte. ► Elevated CD44+ lymphocytes demonstrate lower DFS in NPC undergoing radiochemotherapy. ► CD44+ lymphocyte is a promising independent predictor of survival for NPC patients.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Preview
Unfavorable clinical implications of circulating CD44+ lymphocytes in patients with nasopharyngeal carcinoma undergoing radiochemotherapy
Authors
, , , , , , ,